Tuesday, November 19, 2024
HomeIndustriesHealthcare

Healthcare

BayCare Receives Recognition for its Minimally Invasive Transcatheter Valve Procedures

The structural heart programs at BayCare Morton Plant Hospital in Clearwater and St. Joseph's Hospital in Tampa recently received the American College of Cardiology...

Molecure to Regain Worldwide Rights to Dual Chitinase Inhibitor OATD-01

Molecure S.A. a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and develop first in class small molecule drug...

Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting

Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, announced that the Company presented new preclinical data demonstrating the...

CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous...

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that the Italian Medicines Agency, or Agenzia Italiana del...
0FansLike
0FollowersFollow
spot_img

Hot Topics